Rundu Pharma: Hydrochlorothiazide receives approval for chemical raw material drug listing application
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Rundu Pharma announced that the company recently received the "Approval Notice for the Market Application of Chemical Raw Materials" issued by the National Medical Products Administration for hydrochlorothiazide. This product is suitable for edema diseases, hypertension, central or renal diabetes insipidus, and nephrolithiasis
According to the Zhitong Finance APP, Rundu Pharma (002923.SZ) announced that the company recently received the approval notice for the marketing application of hydrochlorothiazide issued by the National Medical Products Administration. This product is suitable for edema diseases, hypertension, central or renal diabetes insipidus, and nephrolithiasis